Literature DB >> 27416371

Effect of Aged Garlic Extract on the Cytotoxicity of Alzheimer β-Amyloid Peptide in Neuronal PC12 Cells.

B Griffin1, M Selassie1, E T Gwebu1.   

Abstract

Alzheimer's disease (AD) is the most common cause of progressive intellectual failure and memory impairment among the elderly, affecting over 4 million Americans. A hallmark of the disease is the accumulation of β-amyloid, whose neurotoxicity has been well documented. A therapeutic approach may be to ameliorate this toxicity. Garlic has antioxidant, anti-aging and anti-ischemic properties. The purpose of the present study was to determine whether aged garlic extract attenuates the effect of neurotoxin, β-amyloid 25-35 (Aβ) in neuronal PC12 cells. Proliferating (non-neuronal) PC12 cells were treated with the nerve growth factor for at least 4 days before experiments were initiated. This treatment differentiates PC12 cells to a neuronal cell line. Cell viability was determined using the MTS-based assay (Promega). Wakunaga of America (Mission Viejo, CA) kindly donated aged garlic extract(TM) (AGE(TM)) as Kyolic(R) liquid. AGE(TM) was sterilized by filtration and diluted in cell growth medium. Our results show that AGE™ protects neuronal PC12 cells against Aβ (95nM) toxicity in a dose dependent manner. AGE(TM) may be effective in ameliorating Aβ -neurotoxicity.

Entities:  

Keywords:  Aged garlic extract; Cell viability; Cytotoxicity; Nerve growth factor; PC12 cells; β-Amyloid

Year:  2000        PMID: 27416371     DOI: 10.1080/1028415X.2000.11747310

Source DB:  PubMed          Journal:  Nutr Neurosci        ISSN: 1028-415X            Impact factor:   4.994


  3 in total

1.  Aged garlic extract suppresses lipid peroxidation induced by beta-amyloid in PC12 cells.

Authors:  B Griffin; M Selassie; E T Gwebu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-05       Impact factor: 2.416

Review 2.  Therapeutic Potential of Allicin and Aged Garlic Extract in Alzheimer's Disease.

Authors:  Paola Tedeschi; Manuela Nigro; Alessia Travagli; Martina Catani; Alberto Cavazzini; Stefania Merighi; Stefania Gessi
Journal:  Int J Mol Sci       Date:  2022-06-22       Impact factor: 6.208

3.  Sulfur-containing therapeutics in the treatment of Alzheimer's disease.

Authors:  Haizhou Zhu; Venkateshwara Dronamraju; Wei Xie; Swati S More
Journal:  Med Chem Res       Date:  2021-01-15       Impact factor: 1.965

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.